AI assistant
Merck & Co., Inc. — Director's Dealing 2021
May 6, 2021
284_dirs_2021-05-06_33dc5e6f-eae0-4cf1-b7bf-5dd7490d0afe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-05-04
Reporting Person: LeCointe-Cephas Lisa (SVP Chief Ethics & Com Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-04 | Common Stock | M | 694 | $75.98 | Acquired | 2612.346 | Direct |
| 2021-05-04 | Common Stock | F | 238 | $75.98 | Disposed | 2374.346 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-04 | Stock Option (Right to Buy) | $75.99 | A | 18367 | Acquired | 2031-05-03 | Common Stock (18367) | Direct |
| 2021-05-04 | Restricted Stock Unit | $ | A | 2369 | Acquired | 2024-05-04 | Common Stock (2369) | Direct |
| 2021-05-04 | Restricted Stock Unit | $ | M | 694 | Disposed | 2021-05-04 | Common Stock (694) | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
F5: These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.